KeyCorp Raises R1 RCM Price Target to 17.00
| RCMDelisted Stock | USD 14.31 0.01 0.07% |
About 56% of R1 RCM's investor base is looking to short. The analysis of current outlook of investing in R1 RCM Inc suggests that many traders are alarmed regarding R1 RCM's prospects. R1 RCM's investing sentiment overview a quick insight into current market opportunities from investing in R1 RCM Inc. Many technical investors use R1 RCM Inc stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
RCM |
R1 RCM had its price target upped by KeyCorp from 13.00 to 17.00 in a report released on Thursday, Benzinga reports. They currently have an overweight rating on the healthcare providers stock. Several other research firms have also commented on RCM. Morgan Stanley upgraded R1 RCM from an equal weight rating
Read at thelincolnianonline.com
 |
R1 RCM Fundamental Analysis
We analyze R1 RCM's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of R1 RCM using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of R1 RCM based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Income
Net Income Comparative Analysis
R1 RCM is currently under evaluation in net income category among its peers. Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
R1 RCM Inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with R1 RCM stock to make a market-neutral strategy. Peer analysis of R1 RCM could also be used in its relative valuation, which is a method of valuing R1 RCM by comparing valuation metrics with similar companies.
Peers
R1 RCM Related Equities
| HQY | HealthEquity | 2.33 | ||||
| PRVA | Privia Health | 1.78 | ||||
| NRC | National Research | 0.93 | ||||
| SLP | Simulations Plus | 0.27 | ||||
| FORA | Forian | 0.00 | ||||
| HSTM | HealthStream | 0.16 | ||||
| HCAT | Health Catalyst | 0.18 | ||||
| DH | Definitive Healthcare | 0.25 | ||||
| CERT | Certara | 0.85 | ||||
| EVH | Evolent Health | 1.57 |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Consideration for investing in RCM Stock
If you are still planning to invest in R1 RCM Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the R1 RCM's history and understand the potential risks before investing.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |